Elena Cowan

ORCID: 0000-0003-0491-374X
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • COVID-19 Clinical Research Studies
  • SARS-CoV-2 and COVID-19 Research
  • Long-Term Effects of COVID-19
  • Heart Failure Treatment and Management
  • Iron Metabolism and Disorders
  • Intensive Care Unit Cognitive Disorders
  • Erythropoietin and Anemia Treatment
  • Chronic Disease Management Strategies
  • Patient Safety and Medication Errors
  • Respiratory Support and Mechanisms
  • Hemoglobinopathies and Related Disorders
  • Healthcare Technology and Patient Monitoring
  • Potassium and Related Disorders
  • Cardiovascular Syncope and Autonomic Disorders
  • Pharmaceutical Practices and Patient Outcomes
  • Cardiac Arrest and Resuscitation
  • Esophageal and GI Pathology
  • Gallbladder and Bile Duct Disorders
  • Healthcare Systems and Practices
  • Pneumonia and Respiratory Infections
  • Vaccine Coverage and Hesitancy
  • Quality and Safety in Healthcare
  • Human-Automation Interaction and Safety
  • Pancreatic and Hepatic Oncology Research
  • Alcohol Consumption and Health Effects

Queen Alexandra Hospital
2015-2024

John Radcliffe Hospital
2024

Oxford University Hospitals NHS Trust
2024

Portsmouth Hospitals NHS Trust
2017-2023

The Recovery Center
2022

Nepal Health Research Council
2021

NIHR Clinical Research Network
2021

National Institute for Health Research
2021

National Records of Scotland
2021

Intensive Care National Audit & Research Centre
2021

Paul R. Kalra John G.F. Cleland Mark C. Petrie Elizabeth Thomson Philip A. Kalra and 95 more Iain Squire Fozia Ahmed Abdallah Al‐Mohammad Peter J. Cowburn Paul W X Foley Fraser J Graham Alan G Japp Rebecca Lane Ninian N. Lang Andrew Ludman Iain C. Macdougall Pierpaolo Pellicori Robin Ray Michele Robertson Alison Seed Ian Ford Paul R. Kalra John G.F. Cleland Mark C. Petrie Elizabeth Thomson Philip A. Kalra Iain Squire Fozia Ahmed Abdallah Al‐Mohammad Peter J. Cowburn Paul W X Foley Fraser J Graham Alan G Japp Rebecca Lane Ninian N. Lang Andrew Ludman Iain C. Macdougall Pierpaolo Pellicori Robin Ray Michele Robertson Alison Seed Ian Ford Nicholas A. Boon Shannon Amoils Callum Chapman Thomas G Diness Robin Ray Richard Mindham Pamela Sandu Claes Christian Strom Maureen Travers Robert Wilcox Allan D. Struthers Patrick B. Mark Christopher J. Weir Elena Cowan Charlotte Turner Rosalynn Austin Paula Rogers Badri Chandrasekaran Eva Fraile Lynsey Kyeremeh Lorraine McGregor Joanna Osmanska Bernhard Meyer Faheem Ahmad Jude Fisher Christina Summersgill Katarzyna Adeniji Rajkumar Chinnadurai Lisa Massimo Clare S. Hardman Daisy Sykes Sarah Frank Simon Smith Mohamed Anwar Beth Whittington Vennessa Sookhoo Sinéad Lyons Janet Middle Kay Housley Andrew L. Clark Jeanne Bulemfu Christopher Critoph Victor Chong Stephen J. Wood Benjamin R. Szwejkowski Chim C. Lang Jackie Duff Susan M. MacDonald Rebekah Schiff John Donnelly Thuraia Nageh Swapna Kunhunny Roy S. Gardner Marion McAdam Elizabeth McPherson Prithwish Banerjee Eleanor Sear Nigel Edwards

10.1016/s0140-6736(22)02083-9 article EN cc-by The Lancet 2022-11-05
John G.F. Cleland Philip A. Kalra Pierpaolo Pellicori Fraser J Graham Paul W X Foley and 95 more Iain Squire Peter J. Cowburn Alison Seed Andrew L. Clark Ben Szwejkowski Prithwish Banerjee Justin Cooke Mark Francis Piers Clifford Aaron Wong Colin J. Petrie John J.V. McMurray Elizabeth Thomson Kirsty Wetherall Michele Robertson Ian Ford Paul R. Kalra Paul R. Kalra Elena Cowan Charlotte Turner Rosalynn Austin Rebeca Lane Paula Rogers Paul Foley Badri Chandrasekaran Eva Fraile Lynsey Kyeremeh Fozia Ahmed Mark C. Petrie Lorraine McGregor Joanna Osmanska Fraser J Graham Ninian N. Lang Bernhard Meyer Faheem Ahmad Joanna Osmanska Iain Squire Jude Fisher Philip A. Kalra Christina Summersgill Katarzyna Adeniji Rajkumar Chinnadurai Andrew Ludman Lisa Massimo Clare S. Hardman Daisy Sykes Peter J. Cowburn Sarah Frank Simon Smith Alan G. Japp Mohamed Anwar Beth Whittington Alison Seed Robin Ray Vennessa Sookhoo Sinéad Lyons Abdallah Al‐Mohammad Janet Middle Kay Housley Andrew L. Clark Jeanne Bulemfu Christopher Critoph Victor Chong Stephen J. Wood Benjamin R. Szwejkowski Chim C. Lang Jackie Duff Susan M. MacDonald Rebekah Schiff John Donnelly Thuraia Nageh Swapna Kunhunny Mark C. Petrie Roy S. Gardner Marion McAdam Elizabeth McPherson Prithwish Banerjee Eleanor Sear Nigel Edwards Jason Glover Pierpaolo Pellicori Clare Murphy Justin Cooke Charles Spencer Mark Francis Iain Matthews Hayley McKie Andrew Marshall Janet Large Jenny Stratford Piers Clifford Christopher J. Boos Philip J. Keeling Aaron Wong Deborah J. Jones

Abstract Background and Aims What is the relationship between blood tests for iron deficiency, including anaemia, response to intravenous in patients with heart failure? Methods In IRONMAN trial, 1137 failure, ejection fraction ≤ 45%, either serum ferritin < 100 µg/L or transferrin saturation (TSAT) 20% were randomized ferric derisomaltose (FDI) usual care. Relationships investigated baseline anaemia severity, TSAT, changes haemoglobin from 4 months, Minnesota Living Heart Failure...

10.1093/eurheartj/ehae086 article EN cc-by European Heart Journal 2024-03-06

Objective To describe the population, heart failure (HF) diagnosis rate, and 1-year hospitalisation mortality of patients with suspected HF elevated N-terminal pro B-type natriuretic peptide (NTproBNP) investigated according to UK National Institute for Health Care Excellence (NICE) guidelines. Methods NICE recommends HF, based on clinical presentation NTproBNP, are referred specialist assessment echocardiography. Patients should be seen within 2 weeks when NTproBNP is >2000 pg/mL (2-week...

10.1136/heartjnl-2019-316511 article EN cc-by-nc Heart 2020-07-20

<h3>Introduction</h3> Renin-angiotensin-aldosterone-system inhibitors (RAASi) are commonly used for a number of indications, including in the management hypertension, proteinuric chronic kidney disease (CKD), post myocardial infarction and heart failure with reduced ejection fraction (HFrEF). Their use is often hindered by hyperkalaemia leading to underutilisation and/or underdosing. <h3>Purpose</h3> Assess perceptions primary secondary healthcare professionals regarding benefits RAASi...

10.1136/heartjnl-2024-bcs.148 article EN other-oa Heart failure 2024-05-27

Objective To understand human factors (HF) contributing to disturbances during invasive cardiac procedures, including frequency and nature of distractions, assessment operator workload. Methods Single centre prospective observational evaluation 194 procedures in three adult catheterisation laboratories over 6 weeks. A proforma frequency, nature, magnitude level procedural risk at the time each distraction/interruption was completed for case. The primary a National Aeronautical Space...

10.1136/openhrt-2020-001260 article EN cc-by-nc Open Heart 2020-12-01
Robin Ray Ian Ford John G.F. Cleland Fraser J Graham Fozia Ahmed and 95 more Abdallah Al‐Mohammad Peter J. Cowburn Chris Critoph Philip A. Kalra Rebecca Lane Andrew Ludman Pierpaolo Pellicori Mark C. Petrie Michelle M. Robertson Alison Seed Iain Squire Paul R. Kalra Paul R. Kalra Elena Cowan Serena Howe Charlotte Turner Rosalynn Austin Rebeca Lane Paula Rogers Paul Foley Badri Chandrasekaran Eva Fraile Lynsey Kyeremeh Fozia Ahmed Mark Petrie Lorraine McGregor Joanna Osmanska Fraser J Graham Ninian N. Lang Bernhard Meyer Faheem Ahmad Joanna Osmanska Iain Squire Jude Fisher Philip A. Kalra Christina Summersgill Katarzyna Adeniji Rajkumar Chinnadurai Andrew Ludman Lisa Massimo Clare S. Hardman Daisy Sykes Peter J. Cowburn Sarah Frank Simon Smith Alan G. Japp Mohamed Anwar Beth Whittington Alison Seed Robin Ray Vennessa Sookhoo Abdallah Al‐Mohammad Janet Middle Kay Housley Andrew L. Clark Jeanne Bulemfu Christopher Critoph Victor Chong Stephen J. Wood Benjamin R. Szwejkowski Chim C. Lang Jackie Duff Susan M. MacDonald Rebekah Schiff John Donnelly Thuraia Nageh Swapna Kunhunny Mark Petrie Roy S. Gardner Marion McAdam Elizabeth McPherson Prithwish Banerjee Eleanor Sear Nigel Edwards Jason Glover Pierpaolo Pellicori Clare Murphy Justin Cooke Charles Spencer Mark L. Francis Iain Matthews Hayley McKie Andrew Marshall Janet Large Jenny Stratford Piers Clifford Sara Tavares Christopher J. Boos Philip J. Keeling Debbie Hughes Aaron Wong Deborah J. Jones Alex James Rhys Williams Stephen J Leslie

BackgroundIn some countries, intravenous (IV) ferric derisomaltose (FDI) is only licensed for treating iron deficiency with anemia. Accordingly, we investigated the effects of FDI in a subgroup patients anemia IRONMAN trial.Method and ResultsIRONMAN enrolled heart failure, left ventricular ejection fraction (LVEF) ≤45% (ferritin <100 µg/L or TSAT <20%), 771 (68%) whom had (hemoglobin <12 g/dL women; <13 men). Patients were randomized, open-label, to (n=397) usual care (n=374) followed median...

10.1016/j.cardfail.2023.10.006 article EN cc-by Journal of Cardiac Failure 2023-11-04

A wide range of medications including antimalarial preparations (chloroquine, hydroxychloroquine), macrolide antibiotics (azithromycin) and the interleukin-6 inhibitor (tocilizumab) may be effective in treating patients with coronavirus disease 2019 (COVID-19). Such agents associated cardiotoxicity, purpose this brief review is to draw attention potential areas pharmacovigilance. These include prolongation QT-interval development occult cardiomyopathy. Alternatively, some seem have minimal...

10.5837/bjc.2021.007 article EN British Journal of Cardiology 2021-01-01

<h3>Background</h3> Inhibitors of the Renin-angiotensin-aldosterone-system (RAASi) offer prognostic advantages in heart failure with reduced ejection fraction (HFrEF), after myocardial infarction (MI) and for those chronic kidney disease (CKD). Nevertheless, when patients develop hyperkalaemia RAASi dosage might be lowered or discontinued, potentially leading to unfavourable outcomes. <h3>Purpose</h3> A prospective observational study at a single center analysed real-world data patient's...

10.1136/heartjnl-2024-bcs.139 article EN other-oa Heart failure 2024-05-27

<h3>Introduction</h3> Palpitations, pre-syncope and syncope is a common presentation to cardiology services. Short monitoring with conventional Holter monitor or cardiac memo often not sufficient for the detection of paroxysmal arrhythmia. The aims this project were: (i) demonstrate symptom-rhythm correlation novel ambulatory ECG devices, (ii) short time diagnosis patient presenting palpitation, syncope, (iii) assess experience.Method: Patients referred local Cardiology Department symptoms...

10.1136/heartjnl-2022-bcs.91 article EN 2022-06-01

<b>Background:</b> The management of IPF has changed since the introduction anti-fibrotic agents Pirfenidone (Pirf) and Nintedanib (Nin) however, there are no studies on head to comparison these agents. <b>Aims:</b> To examine real-world tolerability, efficacy safety Pirf Nin in patients with a diagnosis <b>Methods:</b> We conducted retrospective single centre records review 71 who received or for between Sep 2013 Aug 2016. Data was collected diagnosis, demographics, pulmonary function...

10.1183/1393003.congress-2017.pa4879 article EN 2017-09-01

<h3>Purpose</h3> To understand factors contributing to disturbances during cardiac procedures, including frequency and nature of distractions, along with assessment operator 'work-load' through NASA Task-load indices. <h3>Methods</h3> A single centre prospective observational study was conducted on 194 consecutive patients undergoing procedures in 3 adult CL's over a period 4 weeks. distraction pro-forma completed for each case by CL team members (predominantly physiologists), documenting...

10.1136/heartjnl-2019-bcs.52 article EN Interventional Cardiology 2019-05-01

<h3>Introduction</h3> Chronic heart failure (HF) represents a substantial and growing public health financial burden has poor prognosis. National Institute for Health Care Excellence (NICE) guidelines quality standards recommend timely specialist assessment patients with suspected HF raised natriuretic peptides. However, data on the outpatient population assessed, diagnostic rates of outcomes this pathway are not known. This is in contrast to hospitalised acute who well described UK. Our aim...

10.1136/heartjnl-2019-bcs.81 article EN Heart failure 2019-05-01

<h3>Introduction</h3> Atrial fibrillation (AF) is a global public health priority. An unsolved problem how to detect paroxysmal AF. Patients presenting with palpitations are usually monitored for short period of time conventional 24 hour Holter monitor or 72 hours cardiac memo. As result, it likely that AF being routinely underdiagnosed and undertreated. This service evaluation reviewed the proportion patients amongst those who investigated palpitations/pre-syncope/syncope by Cardiology...

10.1136/heartjnl-2020-bcs.75 article EN 2020-07-01
Coming Soon ...